Verrica Pharmaceuticals Inc. (VRCA): Price and Financial Metrics
VRCA Price/Volume Stats
| Current price | $0.60 | 52-week high | $8.98 |
| Prev. close | $0.59 | 52-week low | $0.38 |
| Day low | $0.57 | Volume | 136,300 |
| Day high | $0.62 | Avg. volume | 346,854 |
| 50-day MA | $0.54 | Dividend yield | N/A |
| 200-day MA | $0.87 | Market Cap | 55.31M |
VRCA Stock Price Chart Interactive Chart >
Verrica Pharmaceuticals Inc. (VRCA) Company Bio
Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. The company is based in West Chester, Pennsylvania.
VRCA Price Returns
| 1-mo | N/A |
| 3-mo | 37.14% |
| 6-mo | -12.32% |
| 1-year | -91.48% |
| 3-year | -71.56% |
| 5-year | -95.77% |
| YTD | -14.29% |
| 2024 | -90.44% |
| 2023 | 166.18% |
| 2022 | -69.98% |
| 2021 | -20.42% |
| 2020 | -27.56% |
Loading social stream, please wait...